JNJ-3534
JNJ-3534 is a small molecule, orally bioavailable RORγt inverse agonist. It is utilized in research to investigate Th17 cell biology and has demonstrated efficacy in preclinical models of autoimmune diseases, supporting its study in both in vitro and in vivo experimental settings.
Product Specifications
Smiles
NA
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog